应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
XNCR Xencor Inc
盘前交易 05-29 08:17:45 EDT
23.40
-0.20
-0.85%
最高
24.09
最低
22.81
成交量
46.30万
今开
23.69
昨收
23.60
日振幅
5.42%
总市值
14.43亿
流通市值
13.04亿
总股本
6,166万
成交额
1,077万
换手率
0.83%
流通股本
5,574万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Xencor, Inc.盘中异动 下午盘快速跳水5.07%报17.99美元
自选股智能写手 · 04-20
Xencor, Inc.盘中异动 下午盘快速跳水5.07%报17.99美元
BTIG:维持Xencor(XNCR.US)评级,由买入调整至买入评级, 目标价由56.00美元调整至38.00美元。
智通财经 · 04-17
BTIG:维持Xencor(XNCR.US)评级,由买入调整至买入评级, 目标价由56.00美元调整至38.00美元。
Xencor, Inc.盘中异动 大幅下跌5.07%
自选股智能写手 · 04-16
Xencor, Inc.盘中异动 大幅下跌5.07%
Xencor, Inc.盘中异动 股价大跌5.06%
自选股智能写手 · 04-10
Xencor, Inc.盘中异动 股价大跌5.06%
Xencor, Inc.盘中异动 大幅拉升5.04%报23.14美元
自选股智能写手 · 03-16
Xencor, Inc.盘中异动 大幅拉升5.04%报23.14美元
公司概况
公司名称:
Xencor Inc
所属市场:
NASDAQ
上市日期:
--
主营业务:
Xencor, Inc.在加利福尼亚州成立于1997年8月,2004年9月在特拉华州重组。该公司是一家临床阶段的生物制药公司,专注于发现和开发工程化的单克隆抗体和细胞因子疗法,以治疗癌症和自身免疫性疾病患者,这些患者的医疗需求尚未得到满足。该公司利用蛋白质工程能力来增加对蛋白质结构和相互作用的理解,并设计新技术和具有改进特性的XmAb候选药物。
发行价格:
--
{"stockData":{"symbol":"XNCR","market":"US","secType":"STK","nameCN":"Xencor Inc","latestPrice":23.4,"timestamp":1716926400000,"preClose":23.6,"halted":0,"volume":463042,"delay":0,"floatShares":55742137,"shares":61662550,"eps":-2.191085,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.2,"latestTime":"05-29 08:17:45 EDT","open":23.69,"high":24.09,"low":22.81,"amount":10766288.169946,"amplitude":0.054237,"askPrice":23.48,"askSize":66,"bidPrice":23.09,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-2.191085,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1716989400000},"adr":0,"listingDate":1386046800000,"adjPreClose":23.4,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":23.4,"preClose":23.4,"latestTime":"18:46 EDT","volume":13568,"amount":317501.09,"timestamp":1716936376052},"volumeRatio":0.8479569753991674},"requestUrl":"/m/hq/s/XNCR/wiki","defaultTab":"wiki","newsList":[{"id":"2428660589","title":"Xencor, Inc.盘中异动 下午盘快速跳水5.07%报17.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428660589","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428660589?lang=zh_cn&edition=full","pubTime":"2024-04-20 02:10","pubTimestamp":1713550220,"startTime":"0","endTime":"0","summary":"北京时间2024年04月20日02时10分,Xencor, Inc.股票出现异动,股价大幅下挫5.07%。截至发稿,该股报17.99美元/股,成交量34.5774万股,换手率0.57%,振幅5.17%。Xencor, Inc.股票所在的生物技术行业中,整体跌幅为0.12%。Xencor, Inc.公司简介:Xencor Inc 是一家位于美国的临床阶段生物制药公司。该公司利用其XmAb技术平台开发候选抗体产品,如XmAb5871和XmAb7195。该信息摘要如下:BTIG:维持Xencor评级,由买入调整至买入评级, 目标价由56.00美元调整至38.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404200210217a54284f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404200210217a54284f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428187767","title":"BTIG:维持Xencor(XNCR.US)评级,由买入调整至买入评级, 目标价由56.00美元调整至38.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2428187767","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428187767?lang=zh_cn&edition=full","pubTime":"2024-04-17 00:15","pubTimestamp":1713284107,"startTime":"0","endTime":"0","summary":"BTIG:维持Xencor(XNCR.US)评级,由买入调整至买入评级, 目标价由56.00美元调整至38.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404170015138784e7d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404170015138784e7d0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427202598","title":"Xencor, Inc.盘中异动 大幅下跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427202598","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427202598?lang=zh_cn&edition=full","pubTime":"2024-04-16 21:42","pubTimestamp":1713274973,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日21时42分,Xencor, Inc.股票出现异动,股价快速下挫5.07%。截至发稿,该股报19.09美元/股,成交量3.8176万股,换手率0.06%,振幅2.39%。Xencor, Inc.股票所在的生物技术行业中,整体跌幅为0.53%。其相关个股中,Jaguar Health, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Cullinan Oncology, Inc.涨幅较大,Biorestorative Therapies, Inc.、Jaguar Health, Inc.、Soligenix, Inc.较为活跃,换手率分别为100.32%、34.08%、32.82%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Brainstorm Cell Therapeutics Inc.、Marinus Pharmaceuticals, Inc.,振幅分别为101.56%、21.87%、21.54%。Xencor, Inc.公司简介:Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041621425387e80fa3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041621425387e80fa3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426492655","title":"Xencor, Inc.盘中异动 股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426492655","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426492655?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:34","pubTimestamp":1712756071,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时34分,Xencor, Inc.股票出现波动,股价急速下跌5.06%。截至发稿,该股报20.46美元/股,成交量1.5581万股,换手率0.03%,振幅1.48%。Xencor, Inc.股票所在的生物技术行业中,整体跌幅为1.07%。其相关个股中,Adial Pharmaceuticals, Inc、Tc Biopharm Plc C/Wts 10/02/2028 、Jaguar Health, Inc.涨幅较大,Adial Pharmaceuticals, Inc、Silo Pharma, Inc.、Abvc Biopharma, Inc.较为活跃,换手率分别为1008.65%、67.58%、24.30%,振幅较大的相关个股有Adial Pharmaceuticals, Inc、Silo Pharma, Inc.、X4制药,振幅分别为29.20%、24.26%、13.39%。Xencor, Inc.公司简介:Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041021343187e7f49b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041021343187e7f49b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419816361","title":"Xencor, Inc.盘中异动 大幅拉升5.04%报23.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419816361","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419816361?lang=zh_cn&edition=full","pubTime":"2024-03-16 02:52","pubTimestamp":1710528739,"startTime":"0","endTime":"0","summary":"北京时间2024年03月16日02时52分,Xencor, Inc.股票出现异动,股价大幅上涨5.04%。截至发稿,该股报23.14美元/股,成交量42.8812万股,换手率0.70%,振幅5.13%。Xencor, Inc.股票所在的生物技术行业中,整体跌幅为0.17%。Xencor, Inc.公司简介:Xencor Inc 是一家总部位于美国的临床阶段生物制药公司。Xencor通过研发合作以及内部开发的候选药物的许可获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240316025219861debbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240316025219861debbb&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xencor.com","stockEarnings":[{"period":"1week","weight":-0.0156},{"period":"1month","weight":0.1712},{"period":"3month","weight":0.0268},{"period":"6month","weight":0.2759},{"period":"1year","weight":-0.1413},{"period":"ytd","weight":0.1022}],"compareEarnings":[{"period":"1week","weight":-0.0029},{"period":"1month","weight":0.0424},{"period":"3month","weight":0.0465},{"period":"6month","weight":0.1608},{"period":"1year","weight":0.2614},{"period":"ytd","weight":0.1147}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Xencor, Inc.在加利福尼亚州成立于1997年8月,2004年9月在特拉华州重组。该公司是一家临床阶段的生物制药公司,专注于发现和开发工程化的单克隆抗体和细胞因子疗法,以治疗癌症和自身免疫性疾病患者,这些患者的医疗需求尚未得到满足。该公司利用蛋白质工程能力来增加对蛋白质结构和相互作用的理解,并设计新技术和具有改进特性的XmAb候选药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.272727,"avgChangeRate":-0.034038},{"month":2,"riseRate":0.636364,"avgChangeRate":0.063869},{"month":3,"riseRate":0.272727,"avgChangeRate":-0.028292},{"month":4,"riseRate":0.090909,"avgChangeRate":-0.044452},{"month":5,"riseRate":0.636364,"avgChangeRate":0.043264},{"month":6,"riseRate":0.7,"avgChangeRate":0.127212},{"month":7,"riseRate":0.5,"avgChangeRate":-0.012249},{"month":8,"riseRate":0.5,"avgChangeRate":-0.001995},{"month":9,"riseRate":0.3,"avgChangeRate":-0.039286},{"month":10,"riseRate":0.4,"avgChangeRate":-0.022982},{"month":11,"riseRate":0.9,"avgChangeRate":0.139418},{"month":12,"riseRate":0.6,"avgChangeRate":0.028545}],"exchange":"NASDAQ","name":"Xencor Inc","nameEN":"Xencor"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Xencor Inc(XNCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Xencor Inc(XNCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Xencor Inc,XNCR,Xencor Inc股票,Xencor Inc股票老虎,Xencor Inc股票老虎国际,Xencor Inc行情,Xencor Inc股票行情,Xencor Inc股价,Xencor Inc股市,Xencor Inc股票价格,Xencor Inc股票交易,Xencor Inc股票购买,Xencor Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Xencor Inc(XNCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Xencor Inc(XNCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}